Karyopharm Therapeutics Inc. (KPTI) vs NanoViricides, Inc. (NNVC)
Karyopharm Therapeutics Inc. and NanoViricides, Inc. are both Biotechnology companies. Karyopharm Therapeutics Inc. and NanoViricides, Inc. are of similar size ($39.2M and $38.0M). NanoViricides, Inc. has the higher net margin (0.00% vs −153.3%) and the lower return on invested capital (−86.0% vs 0.00%). Across the 13 metrics below, NanoViricides, Inc. leads on 8 and Karyopharm Therapeutics Inc. on 5.
Valuation
Profitability
| Metric | KPTI | NNVC | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.89% | 0.00% | 65.16% |
| Operating margin | (56.17%) | 0.00% | 0.00% |
| Net margin | (153.28%) | 0.00% | 0.00% |
| Free cash flow margin | (44.57%) | 0.00% | 0.00% |
| Return on equity | 78.98% | (89.97%) | (57.72%) |
| Return on assets | (207.90%) | (79.91%) | (49.22%) |
| Return on invested capital | 0.00% | (86.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack